Nutritional Guidelines for Persons Infected with the Hepatitis C Virus: A Review of the Literature

Canadian Journal of Dietetic Practice and Research

Volumn 62, Issue 1, 2001, Pages 7-15

  Wendland, Barbara E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; DISEASE COURSE; HEPATITIS C; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL DISORDER; NUTRITIONAL REQUIREMENT; PATHOLOGY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; VIROLOGY;

ACUTE DISEASE; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; GUIDELINES; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; NUTRITION ASSESSMENT; NUTRITION DISORDERS; NUTRITION PHYSIOLOGY; NUTRITIONAL REQUIREMENTS; RISK FACTORS;

EID: 0035291603     PISSN: 14863847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Canadian Association for Study of the Liver. The management of viral hepatitis. Proceedings of a Consensus Conference, Montreal, QC, March 1999.
2. National Institutes of Health. Management of hepatitis C, NIH Consensus Development Conference, Bethesda, MD, March, 1997.
3. Laboratory Centre for Disease Control, Health Canada, Hepatitis C -prevention and control: a public health consensus. Canada Communicable Disease Report Supplement 1999;25S2:1-22.
4. Health Canada online: http://www.hc-sc.gc.ca/english/search.htm
5. Gully PR, Tepper ML. Hepatitis C. Can Med Assoc J 1997;156(10):1427-1428.
6. Williams, I. Epidemiology of hepatitis C in the United States. Am J Med 1999;107(6B):2S-9S.
7. th ed. London: Blackwell Scientific; 1997. pp. 265-435.
8. th ed. New York: Lippincott Williams and Wilkins; 1998.
9. Schiff ER. The alcoholic patient with hepatitis C virus infection. Am J Med 1999; 107 (6B):95S-99S.
10. Dieterich DT. Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection. Am J Med 1999; 107(6B):79S-84S.
11. Petrides AS, Vogt C, Schulzeberge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994;19:616-627.
12. Carithers RL. Hepatitis C and renal failure. Am J Med 1999; 107(6B):90S-94S.
13. McCullough AJ, Teran JC, Bugianesi E. Guidelines for nutritional therapy in liver disease. In: Klein ES, editor. ASPEN nutritional support practice manual. American Society for Parenteral and Enteral Nutrition; Silver Springs, MD: 1998. p. (12)1-12.
14. Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Muller MJ. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997;16:43-55.
15. Crespo J, Lozano JL, de la Cruz F, Rodrigo L, Rodriguez M, San Miguel G, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994; 89:1147-51.
16. Serfaty L, Aumaitre H, Chazouilleres O, Bonnard AM, Rosmorduc O, Poupon RE, Poupon R. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998; 27:1435-40.
17. Macias J, Pineda JA, Leal MA, Garcia-Pesquera F, Delgado J, Gallardo JA, et al. Influence of hepatitis C infection on the mortality of anti-retroviral-treated patients with HIV disease. Eur J Clin Microbiol Infect Dis 1998; 17:167-70.
18. Ghany MG, Leissinger C, Lagier R, Sanchez-Pescador R, Lok AS. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996; 41:1265-72.
19. Fried MW. Management of hepatitis C in the hemophilia patient. Am J Med 1999; 107(6B):85S-89S.
20. Eyster MF, Alter HJ, Aledort LM, Quan S, Hatzakis A, Goedert JJ. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency deficiency virus (HIV). Ann Int Med 1991:115(10):764-768.
21. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Viladomiu L, Cheung L, et al. Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996:334(26):1691-1696.
22. Shronts E, Fish J. Hepatic Failure. In: Nutrition Support Dietetics: Core Curriculum. American Society for Parenteral and Enteral Nutrition Publications; Silver Springs, MD, 1993. p. 311-325.
23. th ed. Philadelphia, PA: Lea and Febiger, 1999. p. 1177-1189.
24. th ed. Philadelphia, PA: Lea and Febiger, 1994. pp.1066-1080.
25. Regev A, Jeffers LJ. Hepatitis C and alcohol. Alcohol Clin Exp Res 1999; 23(9):1543-51.
26. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, et al. Further evidence for an association between non-insulin dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30(4):1059-63.
27. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29(2):328-33.
28. Konrad T, Vicini P, Zeuzem S, Toffolo G, Breim D, Lorman J. Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease. Exp & Clinical Endocrinol & Diabetes 1999;107(6):343-9.
29. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Israel J Med Sci 1996; 32(7):568-70.
30. Grimbert S, Valensi P, Levy-Marchal C, Perret G, Richardet JP, Raffoux C, et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterologie Clinique et Biologique 1996; 20(6-7):544-8.
31. Pietschmann P, Muller C, Woloszczuk. Serum osteocalcin levels are decreased in patients with acute viral hepatitis. Bone & Mineral 1991;13(3):251-6.
32. Shaker JL, Reinus WR, Whyte MP. Hepatitis C associated osteosclerosis: late onset after blood transfusion in an elderly woman. J Clin Endocrinol Metab 1999; 84(1):384-5.
33. Gallego-Rojo FJ, Ganzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Peres R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998; 28(3)695-9.
34. Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 1997;50(5):401-6.
35. Pratico D, Iulaino L, Basili S, Ferro D, Camastra C, Cordova C, et al. Enhanced lipid peroxidation in hepatic cirrhosis. J Invest Med 1998;46:51-57.
36. Larrea E, Beloqui O, Munoz-Navas MA, Civeira MP, Prieto J. Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Rad Biol & Med 1998;24(7-8):1235-41.
37. Hadi Yasa M, Kacmaz M, Serda Ozturk H., Durak I. Antioxidant status of erythrocytes from patients with cirrhosis. Hepato-Gastroent 1999;46(28):2460-3.
38. Von Herbay A, Stahl W, Niederau C, von Laar J, Strohmeyer G, Sies H. Diminished plasma levels of vitamin E in patients with severe viral hepatitis. Free Rad Res 1996;25(6):461-6.
39. Von Herbay A, Stahl W, Niederau C, Sies H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free Rad Res 1997;27(6):599-605.
40. Houglum K, Venkataramani A, Lyche K, Chojkier M. A pilot study of the effects of d-alpha tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology 1997;113(4):1069-73.
41. Haque S, Chandra B, Gerber MA, Lok AS. Iron overload in patients with chronic hepatitis C: a clinico-pathologic study 1996;27(12):1277-81.
42. Shedlofsky SI. Role of iron in the natural history and clinical course of hepatitis C disease. Hepato-Gastroent 1998;45(20):349-55.
43. Beinker NK, Voight MD, Arendse M, Smit J, Stander IA, Kirsch RE. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 1996;25(5):633-8.
44. Sartori M, Andorno S, La Terra G, Boldorini R., Leone F, Pittau S, et al. Evaluation of iron status in patients with chronic hepatitis C. Ital J Gastroenterol Hepatol 1998;30(4):402-4.
45. Bassett SE, Di Bisceglie AM, Bacon BR, Sharp RM, Govindarajan S, Hubbard GB, et al. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees. Hepatology 1999;29(6):1884-1892.
46. Stern E. Two cases of hepatitis C treated with herbs and supplements. J Alternat & Complement Med 1997;3(1):77-82.
47. Patrick L. Hepatitis C: epidemiology and review of complementary/ alternative medicine treatments. Alternat Medicine Rev 1999;4(4):220-38.
48. Wohl D, Falck-Ytter Y, McCullough AJ. Nutrition in liver disease. Clin Persp in Gastro 1999 September/October; 267-274.
49. Campillo B, Bories PN, Pornin B, Devanlay M. Influence of liver failure, ascites, and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition 1997;13(7-8):687-8.
50. Chang WK, Chao YC, Tang HS, Lang HF, Hsu CT. Effects of extra-carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. J Parenter Enterai Nutr 1997;21:96-99.
51. Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology 1997;26(1):40-8.
52. Levine JA, Morgan MY. Weighed dietary intakes in patients with chronic liver disease. Nutrition 1996;12(6):430-5.
53. Verboeket-van de Venne WP, Westerterp KR, van Hoek B, Swan GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liven effects of the pattern of food intake. Gut 1995;36(1):110-6.
54. Davidson HI, Richardson R, Sutherland D, Garden OJ. Macronutrient preference, dietary intake, and substrate utilization among stable cirrhotic patients. Hepatology 1999;29(5):1308-6.
55. Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992;15:782-794.
56. Merli M, Riggio O, Romiti A, Ariosto F, Mango L, Pinto G, et al. Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology 1990;12:106-112.
57. Petrides AS, Schulzeberge D, Vogt C, Matthews DE, Strohmeyer G. Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology 1993;18:284-91.
58. Petrides AS, Stanley T, Matthews DE, Vogt C, Bush AJ, Lambeth H. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology 1998; 28: 141-49.
59. Druml W, Fischer M, Pidlich J, Lenz K. Fat elimination in chronic hepatic failure: long chain vs. medium chain triglycerides. Am J Clin Nutr 1995;61:812-817.
60. Cabre E, Nunez MC, Gonzalez-Huix F, Fernandez-Banares F, Abad A, Gil A, et al. Clinical and nutritional factors predictive of plasma lipid unsaturation deficiency in advanced liver cirrhosis: a logistic regression analysis. Am J Gastro 1993;88:1738-1743.
61. Cabre E, Abad-Lacruz A, Nunez MC, Gonzalez-Huix F, Fernandez-Banares F, Gil A, et al. The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. Am J Gastro 1993;88:718-722.
62. Guarini P, Stanzial AM, Olivieri O, Cassaril M, Galvani S, Pantalena M, et al. Erythrocyte membrane lipids and serum selenium in post-viral and alcoholic cirrhosis. Clin Chim Acta 1998;270:139-150.
63. Kivits G, Ganguli-Swarttouw MA, Christ EJ. The composition of alkanes exhaled air of rats as a result of lipid peroxidation in vivo: effects of dietary fatty acids, vitamin E, and selenium. Biochem Biophys Acta 1981;665:559-70.
64. Nielson K, Kondrup J, Martinsen L, Dossing H, Larsson B, Stilling B, Jensen MG. Long-term oral refeeding of patients with cirrhosis of the liver. Br J Nutr 1995;74(4):557-567.
65. Ballmer PE, Walshe D, McNurlan MA, Watson H, Brunt PW, Garlick PJ. Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification. Hepatol 1993;18:292-297.
66. Italian Multicentre Co-operative Project on Nutrition in Liver Cirrhosis. Nutritional status in cirrhosis. J Hepatol 1994; 21:317-325.
67. Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein calorie malnutrition in liver cirrhosis. Clin Invest 1992;70:478-486.
68. Crawford DHG, Shepherd RW, Halliday JW, Cooksley GW, Golding SD, Cheng WS, Powell LW. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartment. Gastroenterology 1994;106;1611-1617.
69. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is subjective global assessment of nutritional status? J Parent Ent Nutr 1987;11(1):8-13.
70. McCullough AJ, Mullen KD, Kalhan SC. Measurement of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology 1991;14:1102-1111.
71. Naveau S, Belda E, Borotto E, Genuist F, Chaput JC. Comparison of clinical judgment and anthropometric parameters for evaluating nutritional status in patients with alcoholic liver disease. J Hepatol 1995;23:234-235.
72. Loguercio C, Sava E, Marmo R, del Vecchio BC, Coltorti M. Malnutrition in cirrhotic patients: Anthropometric measurements as a method of assessing nutritional status. Br J Clin Pract 1990;44(3):98-101.
73. Caregaro L, Alberino F, Amodio P, Merkel C, Bolognesi M, Angeli P, Gatta A. Malnutrition in alcoholic and virus-related cirrhosis. Amer J Clin Nutr 1996;63(4):602-9.
74. Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of late evening meal on nitrogen balance in patients with cirrhosis of the liver. Br Med J 1989;299:1202-1203.
75. Verboeket-van de Venne WPH, Westerp KR, van Hoek B, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver, effects of pattern of food intake. Gut 1995;36(1):110-116.
76. Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. J Parenteral Enter Nutr 1996; 20(2):159-64.
77. Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, et al. Long-term oral branched chain amino acid treatment in chronic hepatic encephalopathy. J Hepatol 1990;11:92-101.
78. Plauth M, Egberts E-H, Hamster W, Torok M, Muller PH, Brand O, et al. Long-term treatment of latent porto-systemic encephalopathy with branched chain amino acids. A double-blind placebo-controlled crossover trial. J. Hepatol 1993;17:308-314.
79. McCullough AJ, Mullen KD, Kalhan S. Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during amino acid infusion. Hepatology 1998;28:1357-64.
80. Cabre E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, Fernandez-Banares F, et al. Effect of enteral nutrition on the short term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990;98:715-720.